Background
==========

Intervertebral disc degeneration (IDD) is a commonly seen disorder that can lead to degenerative disc diseases. It has been estimated that IDD can contribute to up to 40% of low back pain (LBP) \[[@b1-medscimonit-24-5598]\], which affects 80% of the population during their lifetime \[[@b2-medscimonit-24-5598]\] and is a leading cause of disability in the working-age population \[[@b3-medscimonit-24-5598]\]. IDD is a multifactorial process of changes in cellular and biochemical components of disc tissues that results in structural failure \[[@b4-medscimonit-24-5598]\]. The pathological presentations can be manifested as disc space narrowing, sciatica, disc prolapse, or even spinal stenosis.

The exact etiological and pathological causes of IDD remain convoluted. Previous studies suggested that genetic predispositions were widely involved in the pathogenesis of IDD. In 1998, Videman et al. \[[@b5-medscimonit-24-5598]\] and Jones et al. \[[@b6-medscimonit-24-5598]\], proposed for the first time that genetic mutations were associated with IDD. Subsequently, increasing number of genomic studies focusing on the vitamin D receptor, extracellular matrix metabolism, intervertebral disc formation, inflammatory mediators, and a disintegrin and metalloprotease with thrombospondin motifs (ADAMTS) have been conducted \[[@b5-medscimonit-24-5598],[@b7-medscimonit-24-5598]--[@b11-medscimonit-24-5598]\]. Several studies have used the genome-wide association study (GWAS) to discover candidate genes related to IDD \[[@b12-medscimonit-24-5598]--[@b14-medscimonit-24-5598]\]. The *CHST3* gene and corresponding variant rs4148941 from GWAS studies have been demonstrated to be associated with IDD \[[@b13-medscimonit-24-5598]\]. Candidate-gene association studies have shown that the asporin D14 allele has a high association with IDD in Chinese and Japanese individuals \[[@b14-medscimonit-24-5598]\]. These studies have confirmed that there are strong correlations between genetic predisposition and the occurrence of IDD.

The fat mass and obesity-associated (*FTO*) gene comprises 2 well-defined domains, an N-(residues 32--236, exons 1--5) and a C-(residues 327--498, exons 6--9) terminal domain \[[@b15-medscimonit-24-5598]\]. The N-terminal domain is the catalytic domain of *FTO* that controls lipolytic activity \[[@b16-medscimonit-24-5598]\], energy homeostasis, and energy expenditure \[[@b17-medscimonit-24-5598]\]. The *FTO* gene is potentially associated with the biochemical metabolism of IDD. It has been reported that the degeneration of intervertebral disc, to some extent, is determined by energy metabolism and leptin metabolism. Energy metabolism is critical to the survival of disc cells. The lack of normal energy regulation might accelerate degeneration of intervertebral disc \[[@b18-medscimonit-24-5598]\]. While the *FTO* gene has close relations with energy metabolic balance \[[@b19-medscimonit-24-5598]\], it can be assumed that the dysfunction of the *FTO* gene might lead to imbalance of disc energy metabolism, further causing disc degeneration. In addition, *FTO* can also regulate the function of leptin and improve leptin sensitivity \[[@b20-medscimonit-24-5598],[@b21-medscimonit-24-5598]\]. To our knowledge, leptin can participate in disc cell proliferation and plays a role in the process of intervertebral disc degeneration \[[@b22-medscimonit-24-5598],[@b23-medscimonit-24-5598]\]. Therefore, *FTO* might modulate intervertebral disc metabolism via regulating leptin level and energy metabolic pathways.

Given the role of the *FTO* gene in the onset of IDD, it is worthwhile to initiate association study between single nucleotide polymorphisms (SNPs) of the *FTO* gene and IDD. However, there have been very few studies investigating *FTO* polymorphisms in IDD. To our knowledge, only 2 association studies have been reported worldwide. In 2013, Lao et al. \[[@b24-medscimonit-24-5598]\] carried out a preliminary association study within 80 patients and 80 controls. Their study had a small sample size and only investigated 6 SNPs of the *FTO* gene. Similarly, our research team investigated associations between 44 SNPs in the *FTO* gene and IDD in the Han Chinese population \[[@b25-medscimonit-24-5598]\]. However, the study sample size consisted of only 118 cases and 113 controls. One of the most obvious disadvantages of previous studies is that the small sample size might lead to insufficient credence supports the biological link between the gene and the disease. Therefore, we enrolled 999 participants from the Chinese Han population and conducted the largest sample size case control study to date to explore the association between polymorphisms in the *FTO* gene and the risk of IDD.

Material and Methods
====================

Study population
----------------

A population-based case control investigation was performed for this study. The 1969 candidate participants were sequentially enrolled from the Department of Orthopedics and from the Center of Health Check-up of the Peking Union Medical College Hospital, Beijing, China, between October 2012 and September 2017. All enrolled individuals were screened by a questionnaire about standard risk factors and disease history.

The case group mainly consisted of orthopedic surgery candidates. The main inclusion criteria for the case groups were complaints of discogenic low back pain (LBP) and newly diagnosed IDD through lumbar disc magnetic resonance imaging (MRI) scanning. Participants who were assessed for Pfirrmann grade IV/V were enrolled in the case group \[[@b26-medscimonit-24-5598]\]. If the participants were exposed to known environmental risk factors, such as heavy manual labor, heavy smoking, or occupational driving, then they were not recruited to this study. Participants with spinal and joint diseases, including trauma, spinal tumor, spine deformity, backbone infection, leg length discrepancy, and osteoarthritis, were also excluded from this study. The included participants met the criteria of being from the Chinese Han population and were aged between 18 and 85 years old. For the control group, the primary inclusion criterion was a lack of medical history of LBP or sciatica. According to the flow-chart ([Figure 1](#f1-medscimonit-24-5598){ref-type="fig"}), finally, 502 patients and 497 controls population were eligible for the study.

We asked for the detailed case history and performed thorough physical examinations. All enrolled individuals were then screened by MRI, and the imaging results were interpreted by at least 2 blinded experienced radiologists \[[@b10-medscimonit-24-5598],[@b11-medscimonit-24-5598],[@b27-medscimonit-24-5598]\]. Age and gender matched in both groups. To rule out the confounding factor of body weight in our research, body mass index (BMI) was matched between the case and control groups to guarantee there was no selection bias ([Table 1](#t1-medscimonit-24-5598){ref-type="table"}).

This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences. All participants signed informed consent after detailed description of the project.

Genomic DNA extraction and SNP genotyping
-----------------------------------------

Five milliliters of peripheral blood sample was obtained from every participant for genotyping. The blood was collected in 2% ethylenediaminetetraacetic acid anticoagulant tubes and fully mixed to keep from clotting. DNA was extracted using the QIAGEN Whole Blood Genomic DNA Mini Kit (QIAGEN Inc., Valencia, CA, USA) according to its standard protocol. SNP genotyping was conducted on the Sequenom MassARRAY SNP genotyping platform (Sequenom Inc., San Diego, CA, USA). Five percent of the samples were randomly selected for duplicate analyses as quality controls.

Based on the information accessed from the NCBI SNP database (*<http://www.ncbi.nlm.nih.gov/SNP>*) and the HapMap database (*<http://www.hapmap.org>*), the following SNPs within the *FTO* gene were included: rs6499640, rs1861868, rs8047395, rs62048402, rs1477196, rs1121980, rs8050136, rs9939609, rs7204609, rs17818902, rs17820875, rs11076008, rs9932411, rs9921255, rs2302673, rs2689247, rs16952951, rs16952955, and rs2540766. The criteria for the selection of the SNPs were set in accordance with the published literature \[[@b28-medscimonit-24-5598],[@b29-medscimonit-24-5598]\]. All SNPs had a MAF above 5%.

Statistical analyses
--------------------

Baseline demographic characteristics of the participants in the case and control groups were compared by Student's t-test and the Chi-square test using SPSS software (version 16.0, SPSS Inc., Chicago, IL, USA). The Hardy-Weinberg equilibrium, haplotype block, and linkage disequilibrium patterns were analyzed using the Haploview program (version 4.2, Broad Institute of MIT and Harvard, Cambridge, MA, USA). The allelic, genotypic, and genotype-phenotype association analyses were carried out using UNPHASED software (v.3.1.5 Dudbridge F, MRC Biostatistics Unit, Cambridge, UK). In this study, the sliding window size for haplotype analyses were 3 and 4. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to estimate the relative risk. To test the underlying interaction among selected SNPs within the *FTO* gene, SNP-SNP interaction analyses were also performed. The databases of SNPnexus (*<http://snp-nexus.org/index.html>*), UCSC genome browser (*<http://genome.ucsc.edu/>*) and HaploReg (v4.1) (*<http://archive.broadinstitute.org/mammals/haploreg/haploreg.php>*) were used for SNP annotation. The multi-tissue expression quantitative trait *loci* (eQTL) comparisons were evaluated and displayed by the Genotype-Tissue Expression (GTEx) database (*<https://www.gtexportal.org>*). Spearman rank correlation and logistic regression analyses were used to assess the internal relation between genotypic changes in SNP and the risk of IDD. The significance levels of all these tests were set to 0.05.

Results
=======

Hardy Weinberg equilibrium in our case control study
----------------------------------------------------

We analyzed 19 SNPs, in a 347-kb interval spanning the *FTO* gene, in 502 cases and 497 controls. Of the 19 SNPs successfully genotyped, 2 SNPs (rs2302673 and rs16952951) with *P* values less than 0.05 deviated from the Hardy-Weinberg equilibrium and were excluded from the subsequent analyses ([Table 2](#t2-medscimonit-24-5598){ref-type="table"}).

Allelic frequency analyses
--------------------------

Of the remaining SNPs, rs1121980 exhibited a significant allelic difference between the case and control groups ([Table 3](#t3-medscimonit-24-5598){ref-type="table"}). The risk allele was T, with an OR of 1.306 (95% CI=1.024--1.666, *P*=0.0309). Differences in the allele frequencies of other SNPs were not statistically significant.

Genotypic association analyses for the risk of IDD
--------------------------------------------------

The CT heterozygote of rs1121980 had significantly genotypic frequency distribution between case and control groups (*P*=0.02682). The OR (1.395) and 95% CI (1.047--1.86) value supported the odds of the event was higher in the case group. In contrast, although the AG heterozygote of rs2689247, the AC heterozygote of rs16952955 and the AG heterozygote of rs2540766 were significantly genotypic frequency distribution between case and control groups (*P*=0.004062, 0.006711, 0.01667 respectively), the value of OR and 95% CI indicated that the genotypes of these SNPs do not increase the risk of IDD in case group ([Table 4](#t4-medscimonit-24-5598){ref-type="table"}).

Haplotypic analyses
-------------------

We constructed the haplotype based on the genotype data of 17 SNPs in the *FTO* gene using Haploview software (version 4.2). The pairwise linkage disequilibrium D' values between SNPs and the linkage disequilibrium plots were presented in [Figure 2](#f2-medscimonit-24-5598){ref-type="fig"}. We identified 2 haplotype blocks with significant associations with predisposition to IDD. The first block contained rs62048402, rs1477196, rs1121980, rs8050136, rs9939609, and rs7204609, while the second block contained rs2689247, rs16952955, and rs2540766.

SNP-SNP interactions on the risk of IDD
---------------------------------------

By using UNPHASED software, the results of SNP-SNP interaction analyses showed that there were 5 SNP combinations significantly associated with IDD (1^st^: rs62048402G-rs1477196G-rs1121980T, Global *P* value=0.015; 2^nd^: rs1477196G-rs1121980T-rs8050136C, Global *P* value=0.039; 3^rd^: rs8047395A-rs62048402G-rs1477196G-rs1121980T, Global *P* value=0.035; 4^th^: rs62048402G-rs1477196G-rs1121980T-rs8050136C, Global *P* value=0.028; 5^th^: rs1121980T-rs8050136C-rs9939609T-rs7204609C, Global *P* value=0.007) ([Table 5](#t5-medscimonit-24-5598){ref-type="table"}).

SNPs annotation
---------------

Through SNPnexus databases, which is a database used for SNP annotation and UCSC genome browser, we can know the basic information of certain SNP. In genotypic association analyses, the 4 SNPs (rs1121980, rs2689247, rs16952955, and rs2540766) with *P*-value less than 0.05 were located in the intronic region. By means of HaploReg annotation, we found the 4 intronic SNPs were associated with regulation of promoter and/or enhancer histone (data not shown). They might play biology function in this way in patients.

Multi-tissue eQTL comparisons by GTEx database
----------------------------------------------

[Figure 3](#f3-medscimonit-24-5598){ref-type="fig"} shows that genotype change of rs1121980 can significantly interfere with the *FTO* gene expression in muscle-skeletal system comparing with other tissues (single-tissue *P*-value=3.163e-6). Therefore, this multi-tissue eQTLs comparison of rs1121980 will provide important data that rs1121980 can interfere with the *FTO* gene expression. Through the GTEx database, we also found that rs1121980 and its different genotypes were significantly associated with increased expression of the *FTO* gene (*P* value=0.0000032) ([Figure 4](#f4-medscimonit-24-5598){ref-type="fig"}). The box plot in [Figure 4](#f4-medscimonit-24-5598){ref-type="fig"} provided detailed evidence to demonstrate different genotypes of rs1121980 were associated with different *FTO* gene expressions. The other 3 SNPs (rs2689247, rs16952955, and rs2540766) had no significant eQTLs in the GTEx database.

The relation between different genotypes of SNPs and severity of IDD
--------------------------------------------------------------------

In order to understand the clinical significance of this SNP, we needed to figure out the internal connection between different genotypes and the severity of IDD. Since the previous data showed rs1121980 could affect the expression of the *FTO* gene, from the clinical perspective, we wanted to know whether the genotype changes of rs1121980 would affect the manifestations of lumbar intervertebral disc degeneration. Therefore, in order to clarify the clinical manifestations of the SNP rs1121980, 207 participants whose MRI would qualitatively record the Pfirrmann grade were enrolled in the next analysis processes ([Table 6](#t6-medscimonit-24-5598){ref-type="table"}).

We first analyzed whether genotypic changes in rs1121980 were related to the changes in clinical phenotypes. Thus, we performed Spearman rank correlation analyses using SPSS 16.0. The results showed that the genotypes of CC/CT/TT were related to the changes of Pfirrmann grade, that is, different genotypes of CC/CT/TT can interfere with the Pfirrmann grade (*P* value \<0.05) ([Table 7](#t7-medscimonit-24-5598){ref-type="table"}). This was also consistent with the results of eQLT, in which genotypic was closely linked to *FTO* gene expression.

Second, we performed logistic regression analysis to determine if participants who carried TT, CT, and CC respectively were at progressively increasing risk for IDD. Through logistic regression analyses, we found that with the change of rs1121980 genotype, the risk of TT was higher than CT (OR=2.784, 95% CI=1.052--7.368, *P*=0.039), CT was higher than CC (OR=1.697, 95% CI=1.282--2.245, *P*\<0.01). Also, the risk of TT was significant higher than CC (OR=4.474, 95% CI=1.722--11.628, *P*=0.02). From CC to CT to TT, the risk of IDD gradually increases followed by the values of odd ratio increasing.

However, when performing the same statistical methods for rs2689247, rs16952955, and rs2540766, the results showed that these SNPs had no significant effect on the risk of IDD (data not shown).

Discussion
==========

In this study, we investigated the association of *FTO* gene polymorphisms with risk of IDD in a case control study of 999 Chinese Han participants. To the best of our knowledge, the sample size in this research was the largest among similar association studies. Our results showed that SNP rs1121980 had an allelic association with IDD, and the risk allele of the same SNP was T. Furthermore, we also found 2 haplotype blocks and 5 SNP-SNP combinations that might be indicative of the onset of IDD.

At the allelic level, we found a significant association of the T allele of SNP rs1121980, which locates in the intron region of *FTO*. Scheid et al. created an *FTO* risk score based on 5 SNPs, including rs1121980, and found that the *FTO* risk score did not increase variance accounted for beyond individual *FTO* SNPs \[[@b30-medscimonit-24-5598]\]. Adeyemo et al. investigated the variation of the *FTO* gene in West Africans and replicated the association between rs1121980 and rs7204690 among this population \[[@b31-medscimonit-24-5598]\]. The selection of SNPs in their study might be attributed to the representation of tag SNPs. Some SNPs were able to represent other SNPs in the gene. In addition, the rs1121980 SNP was also associated with hip fracture in women with AA allele as the risk allele, suggesting a potential relationship between this SNP and bone metabolism \[[@b32-medscimonit-24-5598]\]. Since IDD is a degenerative disease affecting the intervertebral disc and the surrounding vertebrae, the association between rs1121980 and hip fracture might serve as evidence supporting our results from a biological point of view.

The hypothesis of our SNP analysis was that if SNPs are associated with IDD, the proportions of different alleles would distribute differently in disease and normal controls. Therefore, we conducted a 2-step verification of rs1121980 and its internal relations with the risk of IDD. First, through GTEx database, we found SNP rs1121980 might interfere with the normal expression of the *FTO* gene in the muscle-skeletal system. Meanwhile, we also found that the rs1121980 and its different genotypes were significantly associated with increased expression of the *FTO* gene. Then, by using Spearman rank correlation and logistic regression analyses, it can be considered that different genotypic changes in rs1121980 might refer to different risk of IDD. Therefore, the present study demonstrated that genotypic changes of rs1121980 in its different alleles were closely related to the risk of IDD. In this sense, the T allele of rs1121980 might be a biomarker for the screening and prognosis of IDD.

SNPs rs2689247, rs16952955, and rs2540766 were reported to be related to osteoporosis phenotypes. In a previous study investigating the association of *FTO* with osteoporosis, the 3 SNPs showed significant association with bone mineral density (BMD) in the hip and spine \[[@b33-medscimonit-24-5598]\]. Two independent experiments of osteoporotic animal models revealed that osteoporosis plays a certain role in the processes of intervertebral disc degeneration and can accelerate the degeneration of intervertebral disc at specific time \[[@b34-medscimonit-24-5598],[@b35-medscimonit-24-5598]\]. However, in the present case control association study, we found that the 3 SNPs could be protective factors. In other words, participants who carried these SNPs might have lower risk against IDD than others in our study cohort. Therefore, our association study showed that there was no direct relationship between rs2689247, rs16952955 and rs2540766 and the risk of IDD.

At the haplotypic level, we identified 2 haplotype blocks significantly associated with the risk of IDD. The haplotype is a set of SNPs that are closer together. Accordingly, those SNPs are more likely to be inherited together \[[@b36-medscimonit-24-5598]\]. The aim of the linkage disequilibrium analysis was to identify those SNPs in IDD patients. The 2 haplotype blocks that we discovered might be indicative of the onset of IDD. The SNP-SNP interaction analysis showed that there were 5 SNP combinations significantly associated with IDD. These SNP combinations showed significant statistical differences in our study cohort. This suggested that those SNP combinations might provide clinical biomarkers for prognosing IDD and also further demonstrated that these genetic variants in the *FTO* gene are significantly associated with the predisposition of IDD.

Two previous studies have reported on the relationship between SNPs of the *FTO* gene and IDD \[[@b24-medscimonit-24-5598],[@b25-medscimonit-24-5598]\]. Nevertheless, this study had the following strengths, by comparing the results of other similar studies. We collected larger sample size and had more stringent inclusion and exclusion criteria to insure the power and reliability of our study. Moreover, our results added novel evidence to support the association between the *FTO* gene and IDD, i.e., the T allele of rs1121980 was the risk allele for IDD. However, there were also some limitations to this study. First, notwithstanding the significant SNP results in our study, functional studies focus on the exact biological mechanisms are important to corroborate, confirm and interpret the role of SNPs in IDD. Nutrient diffusion distance to the nucleus pulpous \[[@b37-medscimonit-24-5598]\], energy metabolism \[[@b18-medscimonit-24-5598]\], leptin regulation \[[@b38-medscimonit-24-5598]\], and increased risk of mechanical failure under loading \[[@b39-medscimonit-24-5598]\] are the possible mechanisms accounting for the generation of IDD. Therefore, further functional studies are needed to elucidate the associations and clarify the precise mechanisms. Second, the genetic architecture and allele frequencies in Chinese people might differ from those in other ethnic populations. Therefore, more generalized studies with larger sample sizes, especially beyond the Chinese Han people, should be performed to investigate whether *FTO* gene polymorphisms are associated with risk of IDD in other ethnic groups.

Conclusions
===========

The present study showed that SNPs of the *FTO* gene were associated with risk of IDD. The T allele of rs1121980 was the risk allele for IDD and it might become a biomarker for the screening and prognosis of IDD. The 2 haplotype blocks and 5 SNP-SNP combinations that we discovered might be indicative of the onset of IDD. Therefore, our study might serve as evidences for future IDD molecular diagnosis.

[Figures 3](#f3-medscimonit-24-5598){ref-type="fig"} and [4](#f4-medscimonit-24-5598){ref-type="fig"} in our manuscript were generated by GTExPortal. The GTEx Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and by NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS. The data used for the analyses described in this manuscript were obtained from: the GTEx Portal (*<https://www.gtexportal.org/home/>*) on 06/20/2018.
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![Flow-chart of 999 study participants in the case and control groups. The course of enrollment and grouping of participants are shown. Finally, we recruited 502 participants in the case group and 497 people in the control group.](medscimonit-24-5598-g001){#f1-medscimonit-24-5598}

![Linkage disequilibrium structures for the 17 SNPs genotyped in the *FTO* gene. The numbers inside the diamonds indicate the D' for pairwise analyses. The colors of the diamonds are shown according to the confidence interval model. SNPs -- single nucleotide polymorphisms. *FTO* gene -- fat mass and obesity-associated gene.](medscimonit-24-5598-g002){#f2-medscimonit-24-5598}

![Multi-tissue eQTL comparison of rs1121980 in GTEx analysis database. The dispersion points of different colors represent the expression of the *FTO* gene in different tissues. The*P* value: from a *t-*test that compares observed beta from single-tissue eQTL analysis to a null beta of 0; the m-value: the posterior probability that an eQTL effect exists in each tissue tested in the cross-tissue meta-analysis. GTEx -- Genotype-Tissue Expression; eQTL -- expression quantitative trait *loci*; *FTO* gene -- fat mass and obesity-associated gene.](medscimonit-24-5598-g003){#f3-medscimonit-24-5598}

![Different rs1121980 genotypes of the *FTO* gene expression in muscle-skeletal tissues. The GTEx database indicated that as the genotype changes (CC→CT→TT), the expression level of the *FTO* gene increases (*P* value=0.0000032). *FTO* gene -- fat mass and obesity-associated gene; GTEx -- Genotype-Tissue Expression.](medscimonit-24-5598-g004){#f4-medscimonit-24-5598}

###### 

Demographic characteristics of participants in case (n=502) and control (n=497) groups.

  Parameter       Case          Control       P values
  --------------- ------------- ------------- ----------
  Age (years)     50.53±12.4    49.52±11.5    0.180
  Gender                                      
   Male           276 (54.9%)   250 (50.3%)   0.145
   Female         226 (45.0%)   247 (49.7%)   
  BMI (kg/m^2^)   25.2±3.4      25.0±3.3      0.245

Data are expressed as mean ± standard deviation (SD), or percentage. Student's t test and Chi-square test were performed to compare the difference of baseline demographic characteristics between participants with IDD and the control group. P\<0.05 indicates statistical significance.

###### 

Hardy-Weinberg equilibrium of the 19 SNPs of *FTO* gene.

  SNPs         Position   ObsHET   PredHET   HW-P value   \% Geno   MAF      Alleles
  ------------ ---------- -------- --------- ------------ --------- -------- ---------
  rs6499640    53769677   0.2428   0.2708    0.6662       93.0      0.4804   A: G
  rs1861868    53790402   0.2835   0.2790    0.6284       93.0      0.3219   A: G
  rs8047395    53798523   0.4477   0.4804    0.2380       93.0      0.4143   A: G
  rs62048402   53803223   0.2027   0.2038    0.6699       93.0      0.2280   A: G
  rs1477196    53808258   0.3898   0.4105    0.0876       93.0      0.2690   A: G
  rs1121980    53809247   0.2567   0.2854    0.5641       93.0      0.3704   C: T
  rs8050136    53816275   0.2008   0.2004    0.5098       94.4      0.3225   A: C
  rs9939609    53820527   0.1996   0.2040    0.6808       92.5      0.3401   A: T
  rs7204609    53833605   0.4677   0.4866    0.2401       93.5      0.2181   C: T
  rs17818902   53871806   0.2124   0.2400    0.1905       93.7      0.2993   G: T
  rs17820875   53926790   0.1588   0.1474    0.0667       93.7      0.1190   A: G
  rs11076008   53927323   0.2138   0.2049    0.8768       93.3      0.3530   A: G
  rs9932411    54005163   0.3665   0.3833    0.1237       94.3      0.4533   C: T
  rs9921255    54009328   0.2461   0.2496    0.2697       92.8      0.1715   C: T
  rs2302673    54068121   0.2629   0.2610    0.0007       93.4      0.2782   A: G
  rs2689247    54097159   0.2450   0.2194    0.0559       93.0      0.1010   A: G
  rs16952951   54099427   0.2409   0.2617    0.0425       93.5      0.0970   A: G
  rs16952955   54099469   0.2428   0.2177    0.0891       93.0      0.0968   A: C
  rs2540766    54105971   0.2339   0.2112    0.1515       93.0      0.1374   A: G

ObsHET -- marker's observed heterozygosity; PredHET -- predicted heterozygosity; MAF -- minor allele frequency. Nineteen SNPs were selected in the *FTO* gene. The positions were shown in this Table.

###### 

Distribution of allelic frequency and association test results.

  SNPs         Allele (1/2)   Control   Case   OR (Allele1=1)   95% CI   *Chi*-square   *P* value                
  ------------ -------------- --------- ------ ---------------- -------- -------------- --------------- -------- --------
  rs6499640    A/G            139       759    161              799      0.9089         0.7094--1.164   0.5723   0.4492
  rs1861868    A/G            157       739    154              806      1.112          0.8714--1.419   0.7280   0.3935
  rs8047395    A/G            535       363    578              363      0.9741         0.809--1.173    0.0770   0.7814
  rs62048402   A/G            103       795    111              849      0.991          0.7452--1.318   0.0039   0.9502
  rs1477196    A/G            263       635    273              687      1.042          0.8526--1.274   0.1632   0.6862
  rs1121980    C/T            759       137    772              182      1.306          1.024--1.666    4.6609   0.0309
  rs8050136    A/C            105       841    108              832      0.9618         0.7232--1.279   0.0716   0.7890
  rs9939609    A/T            101       791    112              844      0.9622         0.7229--1.281   0.0698   0.7917
  rs7204609    C/T            397       531    384              556      1.083          0.9007--1.301   0.7143   0.3980
  rs17818902   G/T            127       805    134              806      0.9489         0.7305--1.233   0.1542   0.6946
  rs17820875   A/G            848       84     858              82       0.9648         0.7015--1.327   0.0485   0.8256
  rs11076008   A/G            117       809    99               839      1.226          0.9221--1.629   1.9706   0.1604
  rs9932411    C/T            235       709    252              688      0.9049         0.7362--1.112   0.9007   0.3426
  rs9921255    C/T            130       764    141              819      0.9884         0.7637--1.279   0.0079   0.9291
  rs2689247    A/G            124       774    109              851      1.251          0.9499--1.647   2.5470   0.1105
  rs16952955   A/C            775       123    852              108      0.7987         0.606--1.053    2.5509   0.1102
  rs2540766    A/G            117       781    106              854      1.207          0.912--1.597    1.7340   0.1879

SNPs -- single nucleotide polymorphisms; OR -- odds ratio; 95% CI -- 95% confidence interval.

###### 

Genotypic frequency distribution of tested SNPs.

  SNPs         Genotype   Case   Control   OR               95% CI       *Chi*-square   Individual *P*-value   Global *P*-value
  ------------ ---------- ------ --------- ---------------- ------------ -------------- ---------------------- ------------------
  rs6499640    AA         11     15        1                1--1         0.9386         0.3326                 0.195998
  AG           139        109    1.739     0.7678--3.938    2.599        0.1069                                
  GG           330        325    1.385     0.6265--3.06     1.473        0.2249                                
  rs1861868    AA         9      15        1                1--1         1.996          0.1577                 0.361883
  AG           136        127    1.785     0.7544--4.222    2.527e-005   0.996                                 
  GG           335        306    1.825     0.7871--4.23     0.2402       0.6241                                
  rs8047395    AA         175    167       1                1--1         0.05394        0.8163                 0.620576
  AG           228        201    1.082     0.8145--1.439    0.6976       0.4178                                
  GG           77         81     0.9072    0.6221--1.323    0.6564       0.2676                                
  rs62048402   AA         5      6         1                1--1         0.1721         0.6782                 0.885044
  AG           101        91     1.332     0.3931--4.512    0.08485      0.7708                                
  GG           374        352    1.275     0.3857--4.215    0.03127      0.8596                                
  rs1477196    AA         44     44        1                1--1         0.1084         0.742                  0.922975
  AG           185        175    1.057     0.6632--1.685    0.0184       0.8921                                
  GG           251        230    1.091     0.6927--1.719    0.1057       0.7451                                
  rs1121980    CC         309    322       1                1--1         5.364          0.02056                0.0674199
  CT           154        115    1.395     1.047--1.86      4.902        0.02682                               
  TT           14         11     1.326     0.593--2.966     0.2021       0.653                                 
  rs8050136    AA         5      5         1                1--1         0.0001024      0.9919                 0.958036
  AC           98         95     1.032     0.2893--3.678    0.08509      0.7705                                
  CC           367        373    0.9839    0.2825--3.427    0.08344      0.7727                                
  rs9939609    AA         5      6         1                1--1         0.1757         0.6751                 0.809703
  AT           102        89     1.375     0.4059--4.66     0.2694       0.6037                                
  TT           371        351    1.268     0.3836--4.193    0.1589       0.6902                                
  rs7204609    CC         82     90        1                1--1         0.5908         0.4421                 0.695358
  CT           220        217    1.113     0.7817--1.584    0.0001597    0.9899                                
  TT           168        157    1.174     0.8113--1.7      0.3748       0.5404                                
  rs17818902   GG         9      14        1                1--1         1.159          0.2818                 0.28424
  GT           116        99     1.823     0.7565--4.391    1.562        0.2114                                
  TT           345        353    1.52      0.6495--3.559    0.6796       0.4097                                
  rs17820875   AA         394    387       1                1--1         0.1037         0.7474                 0.883465
  AG           70         74     0.9291    0.6511--1.326    0.1748       0.6759                                
  GG           6          5      1.179     0.3568--3.894    0.08355      0.7725                                
  rs11076008   AA         4      9         1                1--1         2.016          0.1556                 0.250686
  AG           91         99     2.068     0.6157--6.948    0.5624       0.4533                                
  GG           374        355    2.37      0.7235--7.766    1.289        0.2562                                
  rs9932411    CC         41     31        1                1--1         1.55           0.2131                 0.456327
  CT           170        173    0.743     0.4451--1.24     0.02366      0.8777                                
  TT           259        268    0.7307    0.4446--1.201    0.2675       0.605                                 
  rs9921255    CC         14     10        1                1--1         0.4238         0.5151                 0.767397
  CT           113        110    0.7338    0.3127--1.722    0.1442       0.7041                                
  TT           353        327    0.7711    0.3378--1.76     0.01776      0.894                                 
  rs2689247    AA         14     7         1                1--1         1.935          0.1642                 0.0078855
  AG           81         110    0.3682    0.1422--0.9535   8.256        0.004062                              
  GG           385        332    0.5798    0.2313--1.454    5.172        0.02295                               
  rs16952955   AA         385    333       1                1--1         4.827          0.02802                0.0150537
  AC           82         109    0.6507    0.4716--0.8978   7.349        0.006711                              
  CC           13         7      1.606     0.6335--4.073    1.455        0.2278                                
  rs2540766    AA         12     6         1                1--1         1.653          0.1985                 0.0298244
  AG           82         105    0.3905    0.1406--1.085    5.731        0.01667                               
  GG           386        338    0.571     0.212--1.538     3.562        0.05913                               

SNPs -- single nucleotide polymorphisms; OR -- odds ratio; 95% CI -- 95% confidence interval.

###### 

Significant SNP-SNP interactions in *FTO* gene with IDD.

  SNP combination                            Haplotype   Frequency in case   Frequency in control   Lower 95% CI   Higher 95% CI   Individual *P* value   Global *P* value
  ------------------------------------------ ----------- ------------------- ---------------------- -------------- --------------- ---------------------- ------------------
  rs62048402-rs1477196-rs1121980             G-G-T       0.07218             0.04028                6.498e-008     1.509e+005      0.002159               0.0151691
  rs1477196-rs1121980-rs8050136              G-T-C       0.07559             0.04363                0              0               0.003677               0.0396061
  rs8047395-rs62048402-rs1477196-rs1121980   A-G-G-T     0.07084             0.04028                0              9.573e+041      0.00267                0.0354699
  rs62048402-rs1477196-rs1121980-rs8050136   G-G-T-C     0.07331             0.04021                0              4.488e+042      0.002048               0.0280349
  rs1121980-rs8050136-rs9939609-rs7204609    T-C-T-C     0.01563             0                      1.509e+005     1.195e+006      0.001291               0.00780653

SNP -- single nucleotide polymorphism; 95% CI -- 95% confidence interval. Odds ratio and 95% confidence internals were calculated to estimate the relative risk. P\<0.05 is statistically significant.

###### 

The Pfirrmann grade distribution of study participants.

  Pfirrmann grade   No. of patients
  ----------------- -----------------
  Grade I           5
  Grade II          88
  Grade III         45
  Grade IV          41
  Grade V           28

###### 

Spearman rank correlation analyses between rs1121980 and Pfirrmann grade.

                                                                                       rs1121980                                                   L4 -- L5 Pfirrmann grade
  ------------------------ ----------------------------------------------------------- ----------------------------------------------------------- --------------------------
  rs1121980                Correlation coefficient                                     1.000                                                       0.334
  Sig.(2-tailed)           .                                                           0.000[\*](#tfn6-medscimonit-24-5598){ref-type="table-fn"}   
  N                        207                                                         207                                                         
  L4--L5 Pfirrmann grade   Correlation coefficient                                     0.334                                                       1.000
  Sig.(2-tailed)           0.000[\*](#tfn6-medscimonit-24-5598){ref-type="table-fn"}   .                                                           
  N                        207                                                         207                                                         

p-value \<0.05.
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